Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic

RNA viruses have been posited as triggers for Juvenile Dermatomyositis (JDM). The COVID-19 pandemic proved a unique opportunity to observe the effect of a novel RNA virus on JDM incidence and phenotype. We found the incidence of JDM increased from average of 6.9 cases per year from 2012 to 2019 to 9...

Full description

Bibliographic Details
Main Authors: Christopher Costin, Gabrielle Morgan, Amer Khojah, Marisa Klein-Gitelman, Lauren M. Pachman
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Clinical Immunology Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772613423000070
_version_ 1827917634185723904
author Christopher Costin
Gabrielle Morgan
Amer Khojah
Marisa Klein-Gitelman
Lauren M. Pachman
author_facet Christopher Costin
Gabrielle Morgan
Amer Khojah
Marisa Klein-Gitelman
Lauren M. Pachman
author_sort Christopher Costin
collection DOAJ
description RNA viruses have been posited as triggers for Juvenile Dermatomyositis (JDM). The COVID-19 pandemic proved a unique opportunity to observe the effect of a novel RNA virus on JDM incidence and phenotype. We found the incidence of JDM increased from average of 6.9 cases per year from 2012 to 2019 to 9 cases per year from 2020 to 2021. We compared markers of disease activity in the patients diagnosed with JDM prior to and during the pandemic and found that patients diagnosed with JDM during the pandemic had significantly lower average NK cell counts 90.75(± 76) vs 163(±120) (P = 0.038) and NK cell percentage 3.63% (±2.3) vs. 6.6% (±4.1), (P = 0.008). Other markers of JDM did not significantly change. This study suggests that COVID-19 may be a viral trigger for JDM in selected cases and that NK cell dysregulation may be of particular interest in future research of virally triggered JDM.
first_indexed 2024-03-13T03:31:11Z
format Article
id doaj.art-41bcdaad9ab5455e9d358d7b09c835e4
institution Directory Open Access Journal
issn 2772-6134
language English
last_indexed 2024-03-13T03:31:11Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Clinical Immunology Communications
spelling doaj.art-41bcdaad9ab5455e9d358d7b09c835e42023-06-24T05:20:04ZengElsevierClinical Immunology Communications2772-61342023-12-0134245Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemicChristopher Costin0Gabrielle Morgan1Amer Khojah2Marisa Klein-Gitelman3Lauren M. Pachman4Division of Pediatric Rheumatology, Ann and Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, 225 East Chicago Ave, Box 50, Chicago IL, USA; Corresponding author.Division of Pediatric Rheumatology, Ann and Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, 225 East Chicago Ave, Box 50, Chicago IL, USAPediatric Department, College of Medicine, Umm Al-Qura University, Makkah, Saudi ArabiaDivision of Pediatric Rheumatology, Ann and Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, 225 East Chicago Ave, Box 50, Chicago IL, USADivision of Pediatric Rheumatology, Ann and Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, 225 East Chicago Ave, Box 50, Chicago IL, USARNA viruses have been posited as triggers for Juvenile Dermatomyositis (JDM). The COVID-19 pandemic proved a unique opportunity to observe the effect of a novel RNA virus on JDM incidence and phenotype. We found the incidence of JDM increased from average of 6.9 cases per year from 2012 to 2019 to 9 cases per year from 2020 to 2021. We compared markers of disease activity in the patients diagnosed with JDM prior to and during the pandemic and found that patients diagnosed with JDM during the pandemic had significantly lower average NK cell counts 90.75(± 76) vs 163(±120) (P = 0.038) and NK cell percentage 3.63% (±2.3) vs. 6.6% (±4.1), (P = 0.008). Other markers of JDM did not significantly change. This study suggests that COVID-19 may be a viral trigger for JDM in selected cases and that NK cell dysregulation may be of particular interest in future research of virally triggered JDM.http://www.sciencedirect.com/science/article/pii/S2772613423000070Juvenile dermatomyositisNK CellsCOVID-19
spellingShingle Christopher Costin
Gabrielle Morgan
Amer Khojah
Marisa Klein-Gitelman
Lauren M. Pachman
Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
Clinical Immunology Communications
Juvenile dermatomyositis
NK Cells
COVID-19
title Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
title_full Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
title_fullStr Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
title_full_unstemmed Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
title_short Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
title_sort lower nk cell numbers in children with untreated juvenile dermatomyositis during the covid 19 pandemic
topic Juvenile dermatomyositis
NK Cells
COVID-19
url http://www.sciencedirect.com/science/article/pii/S2772613423000070
work_keys_str_mv AT christophercostin lowernkcellnumbersinchildrenwithuntreatedjuveniledermatomyositisduringthecovid19pandemic
AT gabriellemorgan lowernkcellnumbersinchildrenwithuntreatedjuveniledermatomyositisduringthecovid19pandemic
AT amerkhojah lowernkcellnumbersinchildrenwithuntreatedjuveniledermatomyositisduringthecovid19pandemic
AT marisakleingitelman lowernkcellnumbersinchildrenwithuntreatedjuveniledermatomyositisduringthecovid19pandemic
AT laurenmpachman lowernkcellnumbersinchildrenwithuntreatedjuveniledermatomyositisduringthecovid19pandemic